HUNTER CHRISTOPHER H.
Known title: Chief Executive OfficerCIK: 0001595519
Associated companies
Transaction History
| ACHC | ▼ Sell | Tax Withholding | 5,464 | $114K | 6/26/2025 | View on chart |
| ACHC | ▼ Sell | Tax Withholding | 1,889 | $46K | 5/9/2025 | View on chart |
| ACHC | ▲ Buy | Grant | 115,818 | $0 | 5/5/2025 | View on chart |
| ACHC | ▲ Buy | Grant | 18,781 | $0 | 5/5/2025 | View on chart |
| ACHC | ▼ Sell | Tax Withholding | 1,477 | $40K | 4/11/2025 | View on chart |
| ACHC | ▲ Buy | Grant | 6,672 | $0 | 2/27/2025 | View on chart |
| ACHC | ▲ Buy | Grant | 13,124 | $0 | 2/27/2025 | View on chart |
| ACHC | ▼ Sell | Tax Withholding | 16,995 | $684K | 2/27/2025 | View on chart |
| ACHC | ▲ Buy | Grant | 37,516 | $0 | 6/26/2024 | View on chart |
| ACHC | ▼ Sell | Tax Withholding | 1,899 | $125K | 5/9/2024 | View on chart |
| ACHC | ▼ Sell | Tax Withholding | 1,485 | $113K | 4/11/2024 | View on chart |
| ACHC | ▲ Buy | Grant | 19,822 | $0 | 2/28/2024 | View on chart |
| ACHC | ▲ Buy | Grant | 24,269 | $0 | 2/28/2024 | View on chart |
| ACHC | ▲ Buy | Grant | 14,560 | $0 | 5/9/2023 | View on chart |
| ACHC | ▲ Buy | Grant | 20,926 | $0 | 2/21/2023 | View on chart |
| ACHC | ▲ Buy | Grant | 13,521 | $0 | 4/11/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Acadia Healthcare Sets Q3 2026 Earnings Date
Acadia Healthcare announced the date for its third-quarter 2026 earnings release. This update provides a timeline for the next major financial report from the company. The stock is currently trading within its 52-week range of $11.43 to $35.83, with an average analyst target price of $33.79.
Acadia Healthcare Sets Q3 2026 Earnings Date. Acadia Healthcare announced the date for its third-quarter 2026 earnings release. This update provides a timeline for the next major financial report from the company. The stock is currently trading within its 52-week range of $11.43 to $35.83, with an average analyst target price of $33.79.